Variability in Oxidative Stress-related Genes (, and ) and Susceptibility to Migraine Clinical Phenotypes and Features

Overview

Journal Front Neurol

Specialty Neurology

Date 2023 Jan 26

PMID 36698892

Authors

Maria Papasavva

Michail Vikelis

Vasileios Siokas

Martha-Spyridoula Katsarou

Emmanouil V Dermitzakis

Athanasios Raptis

Aikaterini Kalliantasi

Efthimios Dardiotis

Nikolaos Drakoulis

Affiliations

Soon will be listed here.

Abstract

Introduction: Migraine is a complex disorder with genetic and environmental inputs. Cumulative evidence implicates oxidative stress (OS) in migraine pathophysiology while genetic variability may influence an individuals' oxidative/antioxidant capacity. Aim of the current study was to investigate the impact of eight common OS-related genetic variants [rs4880 (), rs1001179 (), rs1050450 (), rs1695 (), rs1138272 (), rs1799983 (), rs6721961 (), rs660339 ()] in migraine susceptibility and clinical features in a South-eastern European Caucasian population.

Methods: Genomic DNA samples from 221 unrelated migraineurs and 265 headache-free controls were genotyped for the selected genetic variants using real-time PCR (melting curve analysis).

Results: Although allelic and genotypic frequency distribution analysis did not support an association between migraine susceptibility and the examined variants in the overall population, subgroup analysis indicated significant correlation between rs1799983 and migraine susceptibility in males. Furthermore, significant associations of rs1001179 and rs1050450 with disease age-at-onset and migraine attack duration, respectively, were revealed. Lastly, variability in the and genes were associated with sleep/weather changes, alcohol consumption and physical exercise, respectively, as migraine triggers.

Discussion: Hence, the current findings possibly indicate an association of OS-related genetic variants with migraine susceptibility and clinical features, further supporting the involvement of OS and genetic susceptibility in migraine.

Citing Articles

Combining biomarkers of susceptibility with toxicodynamic models: a novel approach for assessing modifying factors.

Dehghani S, Yunesian M J Environ Health Sci Eng. 2024; 22(1):361-364.

PMID: 38887756 PMC: 11180060. DOI: 10.1007/s40201-024-00896-z.

New perspectives on migraine treatment: a review of the mechanisms and effects of complementary and alternative therapies.

Song X, Zhu Q, Su L, Shi L, Chi H, Yan Y Front Neurol. 2024; 15:1372509.

PMID: 38784897 PMC: 11111892. DOI: 10.3389/fneur.2024.1372509.

Oxidative Stress and Migraine.

Jimenez-Jimenez F, Alonso-Navarro H, Garcia-Martin E, Espada-Rubio S, Agundez J Mol Neurobiol. 2024; 61(10):8344-8360.

PMID: 38499906 DOI: 10.1007/s12035-024-04114-7.

A Comprehensive Investigation of Risk Association Between the -786 T > C, + 884 G > A, VNTR, rs743506, rs3918226 of eNOS and Susceptibility of Migraine: A Updated Meta-Analysis Utilizing Trial Sequential Analysis.

Sudershan A, Bhagat M, Singh K, Pushap A, Kumar H, Kumar P J Mol Neurosci. 2023; 73(11-12):956-975.

PMID: 37902933 DOI: 10.1007/s12031-023-02167-2.

Genetic Variability in Vitamin D Receptor and Migraine Susceptibility: A Southeastern European Case-Control Study.

Papasavva M, Vikelis M, Siokas V, Katsarou M, Dermitzakis E, Raptis A Neurol Int. 2023; 15(3):1117-1128.

PMID: 37755360 PMC: 10536141. DOI: 10.3390/neurolint15030069.

References

. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018; 38(1):1-211. DOI: 10.1177/0333102417738202. View

Goncalves F, Luizon M, Speciali J, Martins-Oliveira A, Dach F, Tanus-Santos J . Interaction among nitric oxide (NO)-related genes in migraine susceptibility. Mol Cell Biochem. 2012; 370(1-2):183-9. DOI: 10.1007/s11010-012-1409-5. View

Borroni B, Rao R, Liberini P, Venturelli E, Cossandi M, Archetti S . Endothelial nitric oxide synthase (Glu298Asp) polymorphism is an independent risk factor for migraine with aura. Headache. 2006; 46(10):1575-9. DOI: 10.1111/j.1526-4610.2006.00614.x. View

Chen C, Sheu J, Lin Y, Lin H . Association of migraines with brain tumors: a nationwide population-based study. J Headache Pain. 2018; 19(1):111. PMC: 6755602. DOI: 10.1186/s10194-018-0944-1. View

Liampas I, Siokas V, Mentis A, Aloizou A, Dastamani M, Tsouris Z . Serum Homocysteine, Pyridoxine, Folate, and Vitamin B12 Levels in Migraine: Systematic Review and Meta-Analysis. Headache. 2020; 60(8):1508-1534. DOI: 10.1111/head.13892. View

Genc S, Pennisi M, Yeni Y, Yildirim S, Gattuso G, Altinoz M . Potential Neurotoxic Effects of Glioblastoma-Derived Exosomes in Primary Cultures of Cerebellar Neurons via Oxidant Stress and Glutathione Depletion. Antioxidants (Basel). 2022; 11(7). PMC: 9311852. DOI: 10.3390/antiox11071225. View

Ashina M . Migraine. N Engl J Med. 2020; 383(19):1866-1876. DOI: 10.1056/NEJMra1915327. View

Persico A, Verdecchia M, Pinzone V, Guidetti V . Migraine genetics: current findings and future lines of research. Neurogenetics. 2014; 16(2):77-95. DOI: 10.1007/s10048-014-0433-x. View

Schurks M, Kurth T, Buring J, Zee R . A candidate gene association study of 77 polymorphisms in migraine. J Pain. 2009; 10(7):759-66. PMC: 2704575. DOI: 10.1016/j.jpain.2009.01.326. View

10.

Cordero M, Cano-Garcia F, Alcocer-Gomez E, de Miguel M, Sanchez-Alcazar J . Oxidative stress correlates with headache symptoms in fibromyalgia: coenzyme Q₁₀ effect on clinical improvement. PLoS One. 2012; 7(4):e35677. PMC: 3330812. DOI: 10.1371/journal.pone.0035677. View

11.

Joshi M, Mineo C, Shaul P, Bauer J . Biochemical consequences of the NOS3 Glu298Asp variation in human endothelium: altered caveolar localization and impaired response to shear. FASEB J. 2007; 21(11):2655-63. PMC: 7460804. DOI: 10.1096/fj.06-7088com. View

12.

Matschke V, Theiss C, Matschke J . Oxidative stress: the lowest common denominator of multiple diseases. Neural Regen Res. 2018; 14(2):238-241. PMC: 6301174. DOI: 10.4103/1673-5374.244780. View

13.

Gormley P, Anttila V, Winsvold B, Palta P, Esko T, Pers T . Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet. 2016; 48(8):856-66. PMC: 5331903. DOI: 10.1038/ng.3598. View

14.

Li J, Jiang R, Cong X, Zhao Y . UCP2 gene polymorphisms in obesity and diabetes, and the role of UCP2 in cancer. FEBS Lett. 2019; 593(18):2525-2534. DOI: 10.1002/1873-3468.13546. View

15.

Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z . A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res. 2009; 19(4):519-23. DOI: 10.1038/cr.2009.33. View

16.

Anttila V, Stefansson H, Kallela M, Todt U, Terwindt G, Calafato M . Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat Genet. 2010; 42(10):869-73. PMC: 2948563. DOI: 10.1038/ng.652. View

17.

Khan J, Asoom L, Al Sunni A, Rafique N, Latif R, Saif S . Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine. Biomed Pharmacother. 2021; 139:111557. DOI: 10.1016/j.biopha.2021.111557. View

18.

Bechmann I, Diano S, Warden C, Bartfai T, Nitsch R, Horvath T . Brain mitochondrial uncoupling protein 2 (UCP2): a protective stress signal in neuronal injury. Biochem Pharmacol. 2002; 64(3):363-7. DOI: 10.1016/s0006-2952(02)01166-8. View

19.

Qubty W, Patniyot I . Migraine Pathophysiology. Pediatr Neurol. 2020; 107:1-6. DOI: 10.1016/j.pediatrneurol.2019.12.014. View

20.

Guler S, Gurkan H, Tozkir H, Turan N, Celik Y . An Investigation of the Relationship between the eNOS Gene Polymorphism and Diagnosed Migraine. Balkan J Med Genet. 2015; 17(2):49-59. PMC: 4413442. DOI: 10.2478/bjmg-2014-0074. View